Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Vale

Showing results (631-640 of 830) with videos related to

Pageof 83
Sort By:
Transactions of the Association of American Physicians|January 1, 1988
Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in manR J Urban, S N Pavlou, J E Rivier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1992
Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal womenL A Kolp, S N Pavlou, R J Urban, et al.
Nature|April 12, 1984
Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cellsR T Mason, R A Peterfreund, P E Sawchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2008
Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferationZhengrong Hao, Yan Huang, Jake Cleman, et al.
Methods in Enzymology|January 1, 1986
Assay of growth hormone-releasing factorW Vale, J Vaughan, D Jolley, et al.
Brain Research|February 19, 1996
Characterization of a sheep brain corticotropin releasing factor binding proteinD P Behan, D Cepoi, W H Fischer, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
Human placenta and fetal membranes express human urocortin mRNA and peptideF Petraglia, P Florio, R Gallo, et al.
Neuroendocrinology|April 1, 1980
Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axisC B Nemeroff, G Bissette, J B Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boyM L Vance, D L Kaiser, P M Martha, et al.
Journal of Reproduction and Fertility. Supplement|July 1, 1973
Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factorsR Guillemin, M Amoss, R Blackwell, et al.
Pageof 83

Showing results (631-640 of 830) with videos related to

Sort By:
Pageof 83
Transactions of the Association of American Physicians|January 1, 1988
Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in manR J Urban, S N Pavlou, J E Rivier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1992
Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal womenL A Kolp, S N Pavlou, R J Urban, et al.
Nature|April 12, 1984
Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cellsR T Mason, R A Peterfreund, P E Sawchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2008
Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferationZhengrong Hao, Yan Huang, Jake Cleman, et al.
Methods in Enzymology|January 1, 1986
Assay of growth hormone-releasing factorW Vale, J Vaughan, D Jolley, et al.
Brain Research|February 19, 1996
Characterization of a sheep brain corticotropin releasing factor binding proteinD P Behan, D Cepoi, W H Fischer, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
Human placenta and fetal membranes express human urocortin mRNA and peptideF Petraglia, P Florio, R Gallo, et al.
Neuroendocrinology|April 1, 1980
Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axisC B Nemeroff, G Bissette, J B Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boyM L Vance, D L Kaiser, P M Martha, et al.
Journal of Reproduction and Fertility. Supplement|July 1, 1973
Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factorsR Guillemin, M Amoss, R Blackwell, et al.
Pageof 83